The association of COVID-19 vaccine availability with mental health among adults in the United States

Simple item page
dc.creatorShen, Chen
dc.creatorRashiwala, Lucy
dc.creatorWiener, R. Constance
dc.creatorFindley, Patricia A.
dc.creatorWang, Hao
dc.creatorSambamoorthi, Usha
dc.creator.orcid0000-0001-8311-1360 (Sambamoorthi, Usha)
dc.date.accessioned2022-11-09T15:00:04Z
dc.date.available2022-11-09T15:00:04Z
dc.date.issued2022-08-09
dc.description.abstractObjective: To assess whether COVID-19 vaccine approval and availability was associated with reduction in the prevalence of depression and anxiety among adults in the United States. Methods: We adopted cross sectional and quasi-experimental design with mental health measurements before vaccine availability (June 2020, N = 68,009) and after vaccine availability (March 2021, N = 63,932) using data from Census Pulse Survey. Depression and anxiety were derived from PHQ-2 and GAD-2 questionnaires. We compared rates of depression and anxiety between June 2020 and March 2021. Unadjusted and adjusted analysis with replicate weights were conducted. Results: Depression prevalence was 25.0% in June 2020 and 24.6% in March 2021; anxiety prevalence was 31.7% in June 2020 and 30.0% in March 2021 in the sample. In adjusted analysis, there were no significant differences in likelihood of depression and anxiety between June 2020 and March 2021. Conclusion: Depression and anxiety were not significantly different between June 2020 and March 2021, which suggests that the pandemic effect continues to persist even with widespread availability of vaccines.
dc.description.sponsorshipThis project described was supported in part by the National Institute of General Medical Sciences, 5U54GM104942-05 (RW) and by the National Institutes of Health (NIH) Agreement No. 1OT2OD032581-01 (US) and NIH/1OT2HL158258-01 (US), and the National Institute on Minority Health and Health Disparities through the Texas Center for Health Disparities (NIMHD), 5U54MD006882-10 (HW and US).
dc.identifier.citationShen, C., Rashiwala, L., Wiener, R. C., Findley, P. A., Wang, H., & Sambamoorthi, U. (2022). The association of COVID-19 vaccine availability with mental health among adults in the United States. Frontiers in psychiatry, 13, 970007. https://doi.org/10.3389/fpsyt.2022.970007
dc.identifier.issn1664-0640
dc.identifier.urihttps://hdl.handle.net/20.500.12503/31902
dc.identifier.volume13
dc.publisherFrontiers Media S.A.
dc.relation.urihttps://doi.org/10.3389/fpsyt.2022.970007
dc.rights.holder© 2022 Shen, Rashiwala, Wiener, Findley, Wang and Sambamoorthi.
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceFrontiers in Psychiatry
dc.subjectCovid-19
dc.subjectCensus pulse survey
dc.subjectanxiety
dc.subjectdepression
dc.subjectvaccine availability
dc.titleThe association of COVID-19 vaccine availability with mental health among adults in the United States
dc.typeArticle
dc.type.materialtext

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
full text article
Size:
193.76 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Publications -- Usha Sambamoorthi